Multicenter Trial of EC145 in Advanced, Folate-Receptor Positive Adenocarcinoma of the Lung
Martin J. Edelman(Fox Chase Cancer Center), Edward B. Garon(University of California, Los Angeles), Michael Kraut(University of Bonn), Barbara A. Conley(National Cancer Institute), John Rogers(West Virginia University), Wael A. Harb, Ralph V. Boccia(Center for Cancer and Blood Disorders), Richard A. Messmann, Sridhar E. Pal(Carolinas Medical Center), Philip Bonomi(Rush University Medical Center)
Cited by 36
Related Papers
Determinants of Tumor Response and Survival With Erlotinib in Patients With Non—Small-Cell Lung Cancer
|Journal of Clinical Oncology|2004|1.1k
Avelumab, an anti-PD-L1 antibody, in patients with locally advanced or metastatic breast cancer: a phase 1b JAVELIN Solid Tumor study
|Breast Cancer Research and Treatment|2017|761
Rociletinib in <i>EGFR</i>-Mutated Non–Small-Cell Lung Cancer
|New England Journal of Medicine|2015|664